ArticleClinical pharmacology in drug development2021

Evaluation of the CYP3A and CYP2B6 Drug-Drug Interaction Potential of Lemborexant.

Ishani Landry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.